Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection.

BACKGROUND: Neutrophil recruitment coordinated by intestinal interleukin (IL)-8 secretion is a key component in the pathogenesis of Clostridium difficile infection (CDI). We hypothesized that a common single-nucleotide polymorphism (SNP) in the -251 region of the IL-8 gene promoter may be predictive of recurrent CDI.

METHODS: This was a prospective cohort study of hospitalized adult patients with CDI who were admitted to a large, university-affiliated medical center from 2007 through 2008. Patients were monitored for 3 months after diagnosis of CDI and assessed for recurrent CDI (defined as a return of diarrhea that required treatment after initial symptom resolution). DNA was isolated from blood samples, and genetic sequencing was performed using polymerase chain reaction and pyrosequencing. The association between IL-8 genotype and recurrent CDI was assessed using univariate and multivariate statistics.

RESULTS: Ninety-six patients with a mean (± standard deviation) age of 61 ± 16 years (54% of whom were female and 63% of whom were white) were identified. The overall incidence of recurrent CDI was 24%. IL-8 allele frequency was similar to previously reported findings (for A/A, 27%; for A/T, 53%; and for T/T, 20%). The incidence of recurrent CDI was 38% in patients with the A/A allele and 19% in all other patients (relative risk, 2.1; 95% confidence interval, 1.04-4.13) (P = .043).

CONCLUSIONS: This study indicates that a common SNP in the IL-8 gene promoter is an independent predictor of recurrent CDI. Our results could offer risk stratification for patients at high risk for recurrent CDI.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app